BET bromodomain inhibitor 4
BET bromodomain inhibitor 4 (example 7) is an inhibitor of the BET bromodomain domain[1].
Product Specifications
CAS Number
2407658-41-5
UNSPSC
12352005
Target
Epigenetic Reader Domain
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/bet-bromodomain-inhibitor-4.html
Purity
99.66
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
CC(N=NN1C)=C1C2=CN=C(C3=C2)C(N(N=C4C(C)(O)C)C)=C4N3[C@@H](C5CCOCC5)C6=C(C=CC=N6)F
Molecular Formula
C27H31FN8O2
Molecular Weight
518.59
References & Citations
[1]Preparation of tricyclic compounds as bromodomain and BET inhibitors. World Intellectual Property Organization, WO2020001152 A1 2020-01-02.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC740178-500 1x 500 µL
CD50 (ICAM-3) (186-2G9), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC880149-100 1x 100 µL
CD106 / VCAM1 (1.4C3), CF488A conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC400281-500 1x 500 µL
Insulin (E2-E3), CF640R conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
BNC470965-500 1x 500 µL
MUC1 / CA15-3 / EMA / CD227 (Epithelial Marker) (VU-11D1), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details